about
Extracellular Vesicles and a Novel Form of Communication in the BrainPurification of the aldehyde oxidase homolog 1 (AOH1) protein and cloning of the AOH1 and aldehyde oxidase homolog 2 (AOH2) genes. Identification of a novel molybdo-flavoprotein gene cluster on mouse chromosome 1Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cellsThe molecular assembly of amyloid aβ controls its neurotoxicity and binding to cellular proteinsMyosin as a potential redox-sensor: an in vitro study.Characterization of antimalarial SPf66 peptide using MALDI-TOF MS, CD and SEC.Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis.Isolation of peptides from porcine intestinal tissue that induce extracellular acidification in CHO cells: identification of the active peptide as IGF-I and characterization of a fragment of calponin H1 processed at a dibasic site.Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomicsGlutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systemsCombination of fast chromatographic separations, biosensor-based functional assays, and mass spectrometry for characterization of complex peptide mixtures.Synthetic miniprion PrP106.Redox regulation of cyclophilin A by glutathionylation.Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse.A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein.Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathwayThe toxicity of a mutant prion protein is cell-autonomous, and can be suppressed by wild-type prion protein on adjacent cells.A mouse model of familial ALS has increased CNS levels of endogenous ubiquinol9/10 and does not benefit from exogenous administration of ubiquinol10Redox proteomics: identification of oxidatively modified proteins.Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation.Regulation of redox-sensitive exofacial protein thiols in CHO cells.Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosisA mutant prion protein sensitizes neurons to glutamate-induced excitotoxicityDecreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis.New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models.Peptidylprolyl isomerase A governs TARDBP function and assembly in heterogeneous nuclear ribonucleoprotein complexes.A possible role of transglutaminase 2 in the nucleus of INS-1E and of cells of human pancreatic isletsTransglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E.Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis.Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease.Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes.Nitroproteomics of peripheral blood mononuclear cells from patients and a rat model of ALS.IL-7-induced phosphorylation of the adaptor Crk-like and other targets.RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.Micro-computed tomography for non-invasive evaluation of muscle atrophy in mouse models of disease.IntroductionLack of TNF-alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progressionInsoluble Mutant SOD1 Is Partly Oligoubiquitinated in Amyotrophic Lateral Sclerosis MiceFull-length and N-terminally truncated chicken intestinal diazepam-binding inhibitor
P50
Q26750015-59DFB8B4-D9C4-49FE-B34F-C0F7D8305D63Q28591706-33FF5115-005A-4459-9978-E617BEEF7E72Q28744223-DB63D835-F94C-4188-987B-04A23B95C4AEQ28744600-BED6FB3B-5930-4B23-9192-49E4FFDD39A3Q30371929-11B99665-9024-47C1-A669-BC4581E49891Q30846569-8B509C39-9080-46A8-80BB-837B5EBDB249Q30941385-2EF88252-84A1-428E-9419-569AB371BCDAQ30990137-7A8B03B5-B60B-452B-81F8-760CE6D23950Q31031108-D5F062F9-67A7-401A-9966-5A9D62D18161Q31096762-3B86E85E-CB01-496F-9668-DADAD7C4BA13Q32030191-827AF0D1-1E4F-45D3-A75E-0B94306DDAACQ32129400-E9F52AC4-48A6-4380-9928-55EC6D2A5976Q33230144-5C23D522-FA68-45E7-B4F1-9371554BC853Q33267935-8320FEDB-E7DB-4C06-9218-19DC1975522EQ33748230-8D6CF0DC-6BAF-43C4-A148-C80D8F44321BQ33812876-43409F99-7645-4979-BD7C-34404839CD28Q34200990-0F57FE55-C57B-4B18-B5BE-A40A42DB3844Q34920387-61CC7025-8B58-47AE-80AB-FF10396C93A2Q35181893-BE456DC2-270D-4114-8E7E-423DDE33C187Q36184166-89F2542D-AB2E-422A-8441-DB01FA284792Q36642742-EF435BE4-A27D-4589-86AD-C6AE7C58983BQ36890607-F4FF3767-D040-48DD-9DDE-C40E2B2B7A8AQ37013751-0AE6B0C8-0111-4263-B423-1ACE0AD1C0EEQ37739259-9C5AF959-CB74-42D2-8FDD-94D16F5DCCBFQ38701109-92D274A7-3FD6-46D2-AC95-08CE2DFB010AQ38910098-0176B424-92E8-4E89-832B-BC259F5BF82EQ39051827-31655236-517A-4910-941A-CD88F683E53DQ39387300-6861DC2C-3FD7-49CF-B935-4BCF281CBC94Q40409465-1D4D47CC-4FA4-44CD-BB79-1B53B18D5447Q42463390-8EB167B4-4E9D-4631-84FF-F8E76F1EFD03Q44547310-1DB35DAE-D6BC-4FA0-986D-F0994B9BEE48Q45263012-8AC86EF4-F918-4574-A8F2-204E390B2437Q46086332-9092B1CF-0FC3-4D30-A6F6-11131367C469Q54981646-176668F2-B8FE-4E72-AB96-77C7AB2879BCQ55035170-6526288A-16A0-438C-B777-C6AECBA58D55Q55423762-9D7CD086-3C51-4BAD-9566-648A34556FBAQ60618536-72A0439A-C810-47F0-A869-1F97EEAB3E3BQ60618538-E6799AD5-CF80-47AF-A52E-3080F56A8ABDQ60618581-F84EFDEB-169B-4ED2-882D-DB42D2684F2AQ61051682-6754256A-9B8F-43E2-BDD9-70002CE0A068
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Valentina Bonetto
@ast
Valentina Bonetto
@en
Valentina Bonetto
@es
Valentina Bonetto
@nl
Valentina Bonetto
@sl
type
label
Valentina Bonetto
@ast
Valentina Bonetto
@en
Valentina Bonetto
@es
Valentina Bonetto
@nl
Valentina Bonetto
@sl
prefLabel
Valentina Bonetto
@ast
Valentina Bonetto
@en
Valentina Bonetto
@es
Valentina Bonetto
@nl
Valentina Bonetto
@sl
P106
P1153
6701810094
P21
P31
P496
0000-0003-0456-2054